Cedar Brook Financial Partners, LLC Pfizer Inc Transaction History

Cedar Brook Financial Partners, LLC

$698 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$25.89 - $29.73 $18,381 - $21,108	-710 Reduced 4.84%	13,958 $387,000
Q4 2023 Jan 12, 2024	SELL	$26.13 - $33.94 $37,966 - $49,314	-1,453 Reduced 9.01%	14,668 $422,000
Q3 2023 Oct 17, 2023	SELL	$32.09 - $37.51 $121,043 - $141,487	-3,772 Reduced 18.96%	16,121 $534,000
Q2 2023 Jul 05, 2023	SELL	$36.12 - $41.79 $72,781 - $84,206	-2,015 Reduced 9.2%	19,893 $729,000
Q1 2023 Apr 04, 2023	BUY	$39.39 - $51.28 $56,367 - $73,381	1,431 Added 6.99%	21,908 $893,000
Q4 2022 Feb 01, 2023	BUY	$41.75 - $54.5 $55,569 - $72,539	1,331 Added 6.95%	20,477 $1.05 Million
Q3 2022 Jan 03, 2023	BUY	$43.76 - $53.42 $29,581 - $36,111	676 Added 3.66%	19,146 $837,000
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $41,318 - $48,990	-888 Reduced 4.59%	18,470 $968,000
Q1 2022 Apr 06, 2022	BUY	$45.75 - $56.69 $30,240 - $37,472	661 Added 3.54%	19,358 $1 Million
Q4 2021 Jan 27, 2022	BUY	$41.32 - $61.25 $217,673 - $322,665	5,268 Added 39.23%	18,697 $1.1 Million
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $64,566 - $82,940	-1,645 Reduced 10.91%	13,429 $578,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $98,321 - $111,381	2,738 Added 22.2%	15,074 $590,000
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $169,861 - $191,569	-5,072 Reduced 29.14%	12,336 $447,000
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $56,095 - $71,330	1,676 Added 10.65%	17,408 $641,000
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $91,789 - $107,689	2,891 Added 22.51%	15,732 $547,000
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $5,903 - $7,161	196 Added 1.55%	12,841 $420,000
Q1 2020 May 07, 2020	BUY	$27.03 - $38.62 $69,115 - $98,751	2,557 Added 25.35%	12,645 $413,000
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $78,053 - $88,580	-2,371 Reduced 19.03%	10,088 $395,000
Q3 2019 Oct 24, 2019	SELL	$32.49 - $42.13 $55,850 - $72,421	-1,719 Reduced 12.12%	12,459 $448,000
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $12,536 - $14,075	339 Added 2.45%	14,178 $614,000
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $11,362 - $12,483	303 Added 2.24%	13,839 $588,000
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $520,729 - $593,688	13,536 New	13,536 $560,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.7 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.73 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.46 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.

Account